One dose of Pfizer/BioNtech vaccine cuts COVID-19 infection risk

Muscat: A single dose of the emerging coronavirus vaccine, produced by Pfizer in partnership with BioNtech, can significantly reduce the risk of infection.

A statement issued online by Oman News Agency (ONA) said, ”A British study reveals that a single dose of the emerging coronavirus vaccine, produced by Pfizer in partnership with BioNtech, can significantly reduce the risk of infection.”